Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Ups Legal Reserve, May Break Pfizer's Settlement Record

This article was originally published in The Pink Sheet Daily

Executive Summary

GlaxoSmithkline expects to record a $3.4 billion legal charge relating to a government investigation of its marketing practices and Avandia product liability suits.
Advertisement

Related Content

GSK’s Deal With DoJ Is Fourth In Eight Years; Exec Liability Uncertain
GSK's Lost Quarter: $3 Billion DoJ Settlement Far Outstrips Net Profit
GSK's Lost Quarter: $3 Billion DoJ Settlement Far Outstrips Net Profit
No End In Sight: Pharma Companies Continue To Face Government Probes
Lilly, Novo Nordisk Under Government Investigation For Promotion Of Their Diabetes Drugs
DoJ Case Against GSK Lawyer Flags What Individual Behavior Government May Target
Merck To Join Pfizer and Lilly At Top of DoJ Settlements Chart
FDA Keeps Avandia On The Market But Looks To RECORD For More Clarity On CV Risk
Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.
Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.

Topics

Advertisement
UsernamePublicRestriction

Register

PS071706

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel